What we do
Corporate Governance Advisory Services
ESG Advisory Services
Merger & Acquisition Services
Capital Market Intelligence Services
Proxy Contests, Hostile Takeovers & Shareholder Activism Services
Proxy Solicitation Services
Retail Services and Additional Capabilities
Board of Director Services
Global Debt Services
SPAC Advisory Services
Services for Registered Funds: Mutual Funds, ETFs and Closed-End Funds
Corporate Reputation
Investor Relations
Transaction Communication
Crisis and Issues management
Research
Client Portal

Recent Mergers and Acquisitions

Grifols S.A. acquisition of Biotest AG

Grifols S.A. (NASDAQ: GRFS), a global healthcare leader, acquired Biotest AG (ETR: BIO), a provider of plasma proteins and biological drugs, for $2.2 billion.

Morrow Sodali acted as the information agent in this transaction.

Find more information here.

Topics
Mergers and Acquisitions

Grifols S.A. acquisition of Biotest AG

Topics
Mergers and Acquisitions

Grifols S.A. (NASDAQ: GRFS), a global healthcare leader, acquired Biotest AG (ETR: BIO), a provider of plasma proteins and biological drugs, for $2.2 billion.

Morrow Sodali acted as the information agent in this transaction.

Find more information here.

© 2016 - 2023 Morrow Sodali